Literature DB >> 29122471

3D Registration of mpMRI for Assessment of Prostate Cancer Focal Therapy.

Clément Orczyk1, Andrew B Rosenkrantz2, Artem Mikheev2, Arnauld Villers3, Myriam Bernaudin4, Samir S Taneja5, Samuel Valable4, Henry Rusinek2.   

Abstract

RATIONALE AND
OBJECTIVES: This study aimed to assess a novel method of three-dimensional (3D) co-registration of prostate magnetic resonance imaging (MRI) examinations performed before and after prostate cancer focal therapy.
MATERIALS AND METHODS: We developed a software platform for automatic 3D deformable co-registration of prostate MRI at different time points and applied this method to 10 patients who underwent focal ablative therapy. MRI examinations were performed preoperatively, as well as 1 week and 6 months post treatment. Rigid registration served as reference for assessing co-registration accuracy and precision.
RESULTS: Segmentation of preoperative and postoperative prostate revealed a significant postoperative volume decrease of the gland that averaged 6.49 cc (P = .017). Applying deformable transformation based on mutual information from 120 pairs of MRI slices, we refined by 2.9 mm (max. 6.25 mm) the alignment of the ablation zone, segmented from contrast-enhanced images on the 1-week postoperative examination, to the 6-month postoperative T2-weighted images. This represented a 500% improvement over the rigid approach (P = .001), corrected by volume. The dissimilarity by Dice index of the mapped ablation zone using deformable transformation vs rigid control was significantly (P = .04) higher at the ablation site than in the whole gland.
CONCLUSIONS: Our findings illustrate our method's ability to correct for deformation at the ablation site. The preliminary analysis suggests that deformable transformation computed from mutual information of preoperative and follow-up MRI is accurate in co-registration of MRI examinations performed before and after focal therapy. The ability to localize the previously ablated tissue in 3D space may improve targeting for image-guided follow-up biopsy within focal therapy protocols.
Copyright © 2017 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MRI; Prostate cancer; biopsy; deformable registration; focal therapy; image processing; longitudinal follow-up; three dimensional

Mesh:

Year:  2017        PMID: 29122471      PMCID: PMC6025844          DOI: 10.1016/j.acra.2017.06.010

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  48 in total

1.  Automatic MR volume registration and its evaluation for the pelvis and prostate.

Authors:  Baowei Fei; Andrew Wheaton; Zhenghong Lee; Jeffrey L Duerk; David L Wilson
Journal:  Phys Med Biol       Date:  2002-03-07       Impact factor: 3.609

2.  A spline-based non-linear diffeomorphism for multimodal prostate registration.

Authors:  Jhimli Mitra; Zoltan Kato; Robert Martí; Arnau Oliver; Xavier Lladó; Désiré Sidibé; Soumya Ghose; Joan C Vilanova; Josep Comet; Fabrice Meriaudeau
Journal:  Med Image Anal       Date:  2012-05-15       Impact factor: 8.545

Review 3.  Role of MRI in follow-up after focal therapy for prostate carcinoma.

Authors:  Pieter J De Visschere; Gert O De Meerleer; Jurgen J Fütterer; Geert M Villeirs
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

4.  Tissue deformation and shape models in image-guided interventions: a discussion paper.

Authors:  D J Hawkes; D Barratt; J M Blackall; C Chan; P J Edwards; K Rhode; G P Penney; J McClelland; D L G Hill
Journal:  Med Image Anal       Date:  2004-12-28       Impact factor: 8.545

5.  The detection and significance of subtle changes in mixed-signal brain lesions by serial MRI scan matching and spatial normalization.

Authors:  L Lemieux; U C Wieshmann; N F Moran; D R Fish; S D Shorvon
Journal:  Med Image Anal       Date:  1998-09       Impact factor: 8.545

Review 6.  Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up.

Authors:  Berrend G Muller; Willemien van den Bos; Peter A Pinto; Jean J de la Rosette
Journal:  Curr Opin Urol       Date:  2014-05       Impact factor: 2.309

7.  Prostate cancer: a consensus on trial design for focal therapy.

Authors:  Sangeet Ghai; John Trachtenberg
Journal:  Nat Rev Urol       Date:  2014-03-18       Impact factor: 14.432

Review 8.  New technologies in tumor ablation.

Authors:  Nirmish Singla; Jeffrey Gahan
Journal:  Curr Opin Urol       Date:  2016-05       Impact factor: 2.309

Review 9.  Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective.

Authors:  Riccardo Lencioni; Thierry de Baere; Robert C Martin; Charles W Nutting; Govindarajan Narayanan
Journal:  Liver Cancer       Date:  2015-10-21       Impact factor: 11.740

10.  Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies.

Authors:  Wendy J M van de Ven; Christina A Hulsbergen-van de Kaa; Thomas Hambrock; Jelle O Barentsz; Henkjan J Huisman
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

View more
  1 in total

1.  Role of MRI for the detection of prostate cancer.

Authors:  Richard C Wu; Amir H Lebastchi; Boris A Hadaschik; Mark Emberton; Caroline Moore; Pilar Laguna; Jurgen J Fütterer; Arvin K George
Journal:  World J Urol       Date:  2021-01-04       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.